Teva at ACT 2026

Nov 15–18, 2026 San Antonio, TX ~1.4k attendees Website

Teva takes part in 2 sessions at ACT 2026 in San Antonio. Its program centres on how the risks of excipients, the inactive ingredients in medicines, and of PFAS, the so-called forever chemicals, are explained to the public. It looks at why something judged safe can still feel risky, and how risk communication can address that concern.

Organization	ACT 2026 Attendance
Teva
tevapharm.com Pharmaceutical companies Israeli pharmaceutical company, a major maker of generic medicines that also develops and sells branded specialty drugs.	Session Wed Nov 18 2:00pm–3:15pm Invisible Ingredients, Critical Functions: The Risk Narrative around Excipients and PFAS (S17) Chemical risk assessment 2:00pmWhen Safe Feels Risky: Understanding Public Concern Through the Lens of Risk Communication (S17-1)Teva 2:25pmRisk Communication and Perception of Forever Chemicals and the Consequences for Pharma (S17-2)Johnson & Johnson 2:45pmScience or Speculation? Navigating the Realities of Synthetic Colors and Talc in Drug Products - Addressing the Potential Impact on Pharmaceutical Supply Chains (S17-3)Black Diamond Regulatory Consulting Talk Wed Nov 18 2:00pm–2:25pm Part of Invisible Ingredients, Critical Functions: The Risk Narrative around Excipients and PFAS (S17) When Safe Feels Risky: Understanding Public Concern Through the Lens of Risk Communication (S17-1) Chemical risk assessment

Organization

ACT 2026 Attendance

Teva

tevapharm.com

Pharmaceutical companies

Israeli pharmaceutical company, a major maker of generic medicines that also develops and sells branded specialty drugs.

Session

Wed Nov 18
2:00pm–3:15pm

Invisible Ingredients, Critical Functions: The Risk Narrative around Excipients and PFAS (S17)

Chemical risk assessment

2:00pmWhen Safe Feels Risky: Understanding Public Concern Through the Lens of Risk Communication (S17-1)Teva
2:25pmRisk Communication and Perception of Forever Chemicals and the Consequences for Pharma (S17-2)Johnson & Johnson
2:45pmScience or Speculation? Navigating the Realities of Synthetic Colors and Talc in Drug Products - Addressing the Potential Impact on Pharmaceutical Supply Chains (S17-3)Black Diamond Regulatory Consulting

Talk

Wed Nov 18
2:00pm–2:25pm

Part of Invisible Ingredients, Critical Functions: The Risk Narrative around Excipients and PFAS (S17)

When Safe Feels Risky: Understanding Public Concern Through the Lens of Risk Communication (S17-1)

Chemical risk assessment

Instantly find 20 buyers from Teva

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American College of Toxicology (ACT). Organization details are derived from ACT’s published program, exhibitor floor plan and supporter list, and each organization’s own website. Submit a correction